  |
|
|
|
KaloBios' clinical trials are crucial to the evaluation of new therapies that will address significant unmet medical needs. KaloBios places a high priority on communicating information about active studies to patients and their families.
Currently we are enrolling patients at over 5 sites in Australia (Adelaide, Brisbane, Melbourne, Sydney, and Townsville) for a KB002 trial for rheumatoid arthritis patients. More detailed information about the study can be found at http://www.actr.org.au/trial_view.aspx?ID=1038. If you live in Australia, have rheumatoid arthritis, and are interested in participating in the clinical study, please contact our Australian representative to determine if this study might be suitable for you:
Carolyn Stewart
Ph: +61 412 171010
Fax: +613 9696 9394
carolyn10@iinet.net.au
|
|
